Frenova is the only Phase I-IV drug and device clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North America company, Frenova maintains a world-class network of resources encompassing more than 200 principal investigators and 250 dialysis research sites. We also offer access to more than 183,000 active ESRD patients and 390,000 active CKD patients. By pairing this extensive network with our bioinformatics capabilities to assess your protocol feasibility, drive patient recruitment and enrollment strategies and more, Frenova gives you confidence you can’t get anywhere else. No other clinical development services provider works with a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. When you need to conduct a complete renal clinical program, trust the partner that’s completely renal — Frenova Renal Research.